With similar fashion in other cancers, HSP (0–100 μM, 24–48 h) triggered apoptosis on human pancreatic cell line through attenuating Bcl-xL but increasing the expression of Bax and BAD and inhibiting cell proliferation via reducing the expression of NF-κβ [74]. Here, BCL2L1 is linked to cancer.